Erratum: Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease (Annals of Internal Medicine (2001) 135 (73-87))

Tazeen H. Jafar; Christopher H. Schmid; María S. Landa; Ioannis Giatras; Robert D. Toto; Giuseppe Remuzzi

Related publications

Article2007

Progression Risk, Urinary Protein Excretion, and Treatment Effects of Angiotensin-Converting Enzyme Inhibitors in Nondiabetic Kidney Disease

David M. Kent, Tazeen H. Jafar, Rodney A. Hayward, Hocine Tighiouart, Marcia Landa, Paul de Jong, Dick de Zeeuw, Giuseppe Remuzzi, Anne‐Lise Kamper, Andrew S. Levey

Article2005

Angiotensin-Converting Enzyme Inhibition and Renal Protection in Nondiabetic Patients

Carlos Chiurchiu, Giuseppe Remuzzi, Piero Ruggenenti

Article2024

Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers for Advanced Chronic Kidney Disease

Elaine Ku, Lesley A. Inker, Hocine Tighiouart, Charles E. McCulloch, Ogechi M. Adingwupu, Tom Greene, Raymond O. Estacio, Mark Woodward, Dick de Zeeuw, Julia B. Lewis, Thierry Hannedouche, Tazeen H. Jafar, Enyu Imai, Giuseppe Remuzzi, Hiddo J.L. Heerspink, Fan Fan Hou, Robert D. Toto, Philip Kam‐Tao Li, Mark J. Sarnak

Article1997

Angiotensin-converting enzyme inhibitor therapy for non-diabetic progressive renal disease

Piero Ruggenenti, Giuseppe Remuzzi

Article2015

EXPERT CONSENSUS DOCUMENT ON ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CARDIOVASCULAR DISEASE

J. López‐Sendón, Karl Swedberg, John J.V. McMurray, Juan Tamargo, Aldo Maggioni, Henry Dargie, Michał Tendera, Finn Waagstein, J Kjekshus, Philippe Lechat, Christian Torp‐Pedersen